MedPath

A study involving comparison of the efficacy of TamoxifenVs Letrozole - two hormonal based drugs in treatment of male breast enlargement

Phase 2
Not yet recruiting
Conditions
Health Condition 1: E898- Other postprocedural endocrine andmetabolic complications and disorders
Registration Number
CTRI/2024/04/066186
Lead Sponsor
Institution Government Rajaji hospital madurai medical college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Pubertal gynecomastia of less than 6 months onset

Exclusion Criteria

All Pathological and secondary causes of gynecomastia

- Hypogonadism

- Drug Induced

- Anabolic steroid abuse

Gr IV Pubertal gynecomastia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.